City
Epaper

1 in 3 suffer from fatty liver in India, predates diabetes: Dr Jitendra Singh

By IANS | Updated: July 5, 2024 15:40 IST

New Delhi, July 5 Every third person in India has a fatty liver, which predates Type-2 diabetes and ...

Open in App

New Delhi, July 5 Every third person in India has a fatty liver, which predates Type-2 diabetes and other metabolic disorders, said Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, on Friday.

“Non-alcoholic fatty liver disease (NAFLD) -- a common metabolic liver disorder -- can progress to cirrhosis and primary liver cancer eventually. It predates diabetes, hypertension, heart disease, and many other diseases. As an endocrinologist myself, I understand the nuances of fatty liver and its relation with diabetes and other metabolic disorders,” said Dr Jitendra, a nationally renowned Diabetologist.

He was speaking at the launch of the Indo-French Liver and Metabolic Disease Network (InFLiMeN) -- a virtual node to prevent and cure metabolic liver diseases at the Institute of Liver and Biliary Sciences in the national Capital.

Eleven French and 17 Indian doctors will jointly work in this node.

“Both the Indian subcontinent and Europe are attributable to changes in lifestyle, diet and importantly metabolic syndromes such as diabetes and obesity which have contributed to a significant rise in NAFLD,” the minister said.

He added that in the Indian subcontinent, NAFLD occurs in about 20 per cent of non-obese patients, whereas in the West, most NAFLD is associated with obesity.

He further noted that both India and France have “a considerable burden of alcoholic liver disease (ALD).”

The Union Minister explained that both NAFLD and ALD exhibit a very similar progression from steatosis to steatohepatitis, cirrhosis, and HCC.

“India became a global leader not just in curative healthcare but also in preventive healthcare,” said Dr. Jitendra, highlighting India's progress in the last decade.

He stressed the need for India-specific diagnostics “as our phenotype is different”.

“There is an urgent need to develop simple, low-cost diagnostic tests for the detection of different stages of fatty liver and their progression to severe, full-blown diseases,” he said.

Importantly, he noted that the “approaches and algorithms should suit the Indian context, be low-priced, and have a point of care”.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

BusinessITC Share Price Crash On First Day of New Year 2026 After Modi Govt Hikes Excise Duty On Cigarettes

NationalGujarat govt announces major administrative promotions on first day of 2026

BusinessIn One Year, VinFast Went From a Whisper to a Roar in India's EV Market

NationalCM Fadnavis steps in to quell BJP 'rebellion'; key leaders tasked with damage control

NationalDense fog disrupts flights across North India; airlines issue advisory

National Realted Stories

NationalIndian economy grows strongly over robust domestic demand, benign inflation: RBI

NationalNew Year begins on a wet note for Mumbaikars, unexpected rain drenches parts of city

NationalAfter Bengal administration's failure, ECI to identify housing complexes for polling booths

NationalDoctors' Forum threatens movement against ECI for calling elderly & sick people to SIR hearings

NationalUPI transactions surge 29 pc at at 21.63 billion in Dec, consumption growth remains strong